BRISTOL MYERS SQUIBB CO EPS (Diluted) 2007-2025 | BMY
Beta
What is eps (diluted)?
Diluted earnings per share (EPS) can be defined as net income divided by the total number of shares outstanding including all dilutive securities such as stock options, warrants, and convertible bonds.
What is BRISTOL MYERS SQUIBB CO's current eps (diluted)?
BRISTOL MYERS SQUIBB CO (BMY) annual eps (diluted) for 2025 was $3.46, a 178.46% increase from 2024. BRISTOL MYERS SQUIBB CO eps (diluted) for the quarter ending September 30, 2025 was $1.08.
What was BRISTOL MYERS SQUIBB CO's eps (diluted) in 2024?
BRISTOL MYERS SQUIBB CO annual eps (diluted) for 2024 was $-4.41, a 214.25% decline from 2023.
What was BRISTOL MYERS SQUIBB CO's eps (diluted) in 2023?
BRISTOL MYERS SQUIBB CO annual eps (diluted) for 2023 was $3.86, a 30.85% increase from 2022.
EPS (Diluted) History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGRN/A
FY2020
$-3.99
→
FY2025
$3.46
07080910111213141516171819202122232425
5 years selected
EPS (Diluted) History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $3.46 | +178.5% | 10-K |
| FY2024 | $-4.41 | -214.2% | 10-K |
| FY2023 | $3.86 | +30.8% | 10-K |
| FY2022 | $2.95 | -5.4% | 10-K |
| FY2021 | $3.12 | +178.2% | 10-K |
| FY2020 | $-3.99 | -298.5% | 10-K |
| FY2019 | $2.01 | -33.2% | 10-K |
| FY2018 | $3.01 | +393.4% | 10-K |
| FY2017 | $0.61 | -77.0% | 10-K |
| FY2016 | $2.65 | +184.9% | 10-K |
| FY2015 | $0.93 | -22.5% | 10-K |
| FY2014 | $1.20 | -22.1% | 10-K |
| FY2013 | $1.54 | +32.8% | 10-K |
| FY2012 | $1.16 | -46.3% | 10-K |
| FY2011 | $2.16 | +20.7% | 10-K |
| FY2010 | $1.79 | -66.5% | 10-K |
| FY2009 | $5.34 | +103.8% | 10-K |
| FY2008 | $2.62 | +140.4% | 10-K |
| FY2007 | $1.09 | - | 10-K |
Company: BRISTOL MYERS SQUIBB COTicker: BMYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →